Keitel WA - Search Results

1

Increasing doses of an inactivated influenza A/H1N1 vaccine induce increasing levels of cross-reacting antibody to subsequent, antigenically different, variants.

Keitel WA, Atmar RL, Nino D, Cate TR, Couch RB. Keitel WA, et al. J Infect Dis. 2008 Oct 1;198(7):1016-8. doi: 10.1086/591465. J Infect Dis. 2008. PMID: 18729777

2

Age distribution of patients with medically-attended illnesses caused by sequential variants of influenza A/H1N1: comparison to age-specific infection rates, 1978-1989.

Glezen WP, Keitel WA, Taber LH, Piedra PA, Clover RD, Couch RB. Glezen WP, et al. Among authors: keitel wa. Am J Epidemiol. 1991 Feb 1;133(3):296-304. doi: 10.1093/oxfordjournals.aje.a115874. Am J Epidemiol. 1991. PMID: 2000847

3

Cold recombinant influenza B/Texas/1/84 vaccine virus (CRB 87): attenuation, immunogenicity, and efficacy against homotypic challenge.

Keitel WA, Couch RB, Cate TR, Six HR, Baxter BD. Keitel WA, et al. J Infect Dis. 1990 Jan;161(1):22-6. doi: 10.1093/infdis/161.1.22. J Infect Dis. 1990. PMID: 2153185 Clinical Trial.

4

Effect of live attenuated, cold recombinant (CR) influenza virus vaccines on pulmonary function in healthy and asthmatic adults.

Atmar RL, Bloom K, Keitel W, Couch RB, Greenberg SB. Atmar RL, et al. Vaccine. 1990 Jun;8(3):217-24. doi: 10.1016/0264-410x(90)90049-r. Vaccine. 1990. PMID: 2194380 Clinical Trial.

5

Efficacy of sequential annual vaccination with inactivated influenza virus vaccine.

Keitel WA, Cate TR, Couch RB. Keitel WA, et al. Am J Epidemiol. 1988 Feb;127(2):353-64. doi: 10.1093/oxfordjournals.aje.a114809. Am J Epidemiol. 1988. PMID: 3337087 Clinical Trial.

6

Influenza: its control in persons and populations.

Couch RB, Kasel JA, Glezen WP, Cate TR, Six HR, Taber LH, Frank AL, Greenberg SB, Zahradnik JM, Keitel WA. Couch RB, et al. Among authors: keitel wa. J Infect Dis. 1986 Mar;153(3):431-40. doi: 10.1093/infdis/153.3.431. J Infect Dis. 1986. PMID: 3950437 No abstract available.

7

Comparison of trivalent cold-adapted recombinant (CR) influenza virus vaccine with monovalent CR vaccines in healthy unselected adults.

Atmar RL, Keitel WA, Cate TR, Quarles JM, Couch RB. Atmar RL, et al. Among authors: keitel wa. J Infect Dis. 1995 Jul;172(1):253-7. doi: 10.1093/infdis/172.1.253. J Infect Dis. 1995. PMID: 7797925 Clinical Trial.

8

High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adults.

Keitel WA, Couch RB, Cate TR, Hess KR, Baxter B, Quarles JM, Atmar RL, Six HR. Keitel WA, et al. J Clin Microbiol. 1994 Oct;32(10):2468-73. doi: 10.1128/jcm.32.10.2468-2473.1994. J Clin Microbiol. 1994. PMID: 7814484 Free PMC article. Clinical Trial.

9

Variability in infectivity of cold-adapted recombinant influenza virus vaccines in humans.

Keitel WA, Couch RB, Cate TR, Maassab HF. Keitel WA, et al. J Infect Dis. 1994 Feb;169(2):477. doi: 10.1093/infdis/169.2.477. J Infect Dis. 1994. PMID: 8106789 No abstract available.

10

Pilot evaluation of influenza virus vaccine (IVV) combined with adjuvant.

Keitel W, Couch R, Bond N, Adair S, Van Nest G, Dekker C. Keitel W, et al. Vaccine. 1993;11(9):909-13. doi: 10.1016/0264-410x(93)90376-9. Vaccine. 1993. PMID: 8212835 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters